期刊文献+

miRNA在缺血性脑卒中危险因素中表达的研究进展 被引量:3

Research progress of miRNA in ischemic stroke-related risk factors
原文传递
导出
摘要 脑卒中是目前引起全球人口死亡和导致长期致残的重要原因,缺血性脑卒中的发生率、致残率和死亡率均较高,给社会和家庭均带来沉重负担。微小核糖核酸(miRNA)参与多种生物学过程,如增殖、分化、代谢、突触形成、血管新生和细胞凋亡等,在脑血管病的危险因素中发挥着不可或缺的调节作用。其可能成为缺血性脑卒中快速诊断和治疗效果评价的重要生物标志物,对缺血性脑卒中危险因素的干预提供了预防途径。主要综述miRNA在缺血性脑卒中危险因素如高血压、糖尿病、冠心病、动脉粥样硬化和颈动脉狭窄等中表达的研究进展,以期对疾病的预防和诊治提供新的思路。 Stroke is an important cause of global population death and long-term disability.The incidence,disability,and mortality of ischemic stroke are high,which brings a heavy social and economic burden to society and families.MiRNA is involved in a variety of biological processes,such as proliferation,differentiation,metabolism,synaptic formation,angiogenesis,apoptosis,and so on.MiRNA plays an indispensable regulatory role in the risk factors of a variety of cerebrovascular diseases.In particular,some circulating miRNA have significant changes in the peripheral blood of patients with acute stroke,which may become an important biomarker for rapid diagnosis and treatment of stroke.Intervention on stroke risk factors provides an important way for the prevention of cerebrovascular disease.In this review,the studies on the expression and mechanism of miRNA related to common stroke risk factors,including hypertension,diabetes,coronary heart disease,atherosclerosis,carotid stenosis,depression,age,and stimulating hormones,were summarized to provide new ideas for disease prevention and diagnosis.
作者 刘玲玲 杨霞峰 刘学伍 Liu Lingling;Yang Xiafeng;Liu Xuewu(Department of Neurology,Liaocheng People's Hospital,Liaocheng 252000,China;Department of Neurology,Qilu Hospital of Shandong University,Ji'nan 250012,China)
出处 《国际生物医学工程杂志》 CAS 2022年第6期558-562,共5页 International Journal of Biomedical Engineering
关键词 微小核糖核酸 脑卒中 高血压 糖尿病 冠心病 动脉粥样硬化 颈动脉狭窄 MicroRNA Stroke Hypertension Diabetes mellitus Coronary heart disease Atherosclerosis Carotid artery stenosis
  • 相关文献

参考文献1

二级参考文献18

  • 1Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
  • 2Chen CZ, Li L, Lodish HF, Barrel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83- 86.
  • 3Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. Regulation of miRNA expression during neural cell specification. Eur J Neurosci 2005; 21: 1469-1477.
  • 4Borkhardt A, Fuchs U, Tuschl T. MicroRNA in chronic lymphocytic leukemia. N Engl J Med 2006; 354: 524-525.
  • 5Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M. A pancreatic islet specific microRNA regulates insulin secretion. Nature 2004; 432: 226-230.
  • 6Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007; 129: 303-317.
  • 7van Rooij E, Suthedand LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006; 103:18255-18260.
  • 8Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z. The muscle specific microRNAs miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007; 13: 486-491.
  • 9Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hφydal M, Autore C, Russo MA, Dorn GW 2nd,Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007; 13: 613-618.
  • 10Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34( Database Issue): D140-D144.

共引文献30

同被引文献44

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部